GenAI

News

Amid staff cuts, FDA looks to AI to 'optimise' reviews

The FDA has rolled out its highly-touted generative AI tool, almost a month early, with a promise to reduce the time taken for regulatory reviews.

News

AI trained on NHS data 'may predict ill health in advance'

An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?

Market Access

Streamlining JCA response with GenAI

The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.

News

EVERSANA joins with Veeva in push to 'pharmatise AI'

EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.

Digital

GenAI and the revolution of drug development

Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.

R&D

Reinventing R&D in the age of AI - How intelligent technolog...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human

Amid staff cuts, FDA looks to AI to 'optimise' reviews

AI trained on NHS data 'may predict ill health in advance'

Streamlining JCA response with GenAI

EVERSANA joins with Veeva in push to 'pharmatise AI'

GenAI and the revolution of drug development

Reinventing R&D in the age of AI - How intelligent technolog...

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

GenAI

Editor's Picks